Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
1
Upcoming Catalysts
0
Historical Events
1
Regulatory Approvals
4 competitors in Lupus Nephritis
No patent data available. Pre-approval drugs may not have Orange Book listings.
Saphnelo
Saphnelo is indicated as an add-on therapy for the treatment of adult patients with moderate to severe, active autoantibody-positive systemic lupus erythematosus (SLE), despite standard therapy.
View on EMAIrritable Bowel Syndrome With Constipation (IBS-C)
Muscle Invasive Bladder Cancer
Asthma, Exercise-Induced
Affective Psychosis, Bipolar
Carcinoma, Non-Small-Cell Lung